Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan

Among patients with heart failure and reduced ejection fraction (left ventricular (LV) ejection fraction ≤40%), sacubitril/valsartan (S/V) treatment is associated with improved health status and reverse cardiac remodeling. Data regarding racial and ethnic differences in response to S/V are lacking....

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Nasrien E., Piña, Ileana L., Camacho, Alexander, Bapat, Devavrat, Felker, G. Michael, Maisel, Alan S., Butler, Javed, Prescott, Margaret F., Abbas, Cheryl A., Solomon, Scott D., Januzzi, James L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769180/
https://www.ncbi.nlm.nih.gov/pubmed/33016100
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.007829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769180/
https://www.ncbi.nlm.nih.gov/pubmed/33016100
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.007829

Ejemplares similares